Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

featured

Published in Obesity, Metabolic Syndrome, and Prediabetes

Journal Scan / Research · October 13, 2022

Long-Term Outcomes After Catheter-Based Renal Artery Denervation for Resistant Hypertension

The Lancet

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Jan Basile MD, FACP, FASH, FAHA

Hillel Sternlicht MD

The Lancet

Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial

Lancet 2022 Sep 16;[EPub Ahead of Print], DL Bhatt, M Vaduganathan, DE Kandzari, MB Leon, K Rocha-Singh, RR Townsend, BT Katzen, S Oparil, S Brar, V DeBruin, M Fahy, GL Bakris,

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Obesity, Metabolic Syndrome, and Prediabetes

Long-Term Outcomes After Catheter-Based Renal Artery Denervation for Resistant Hypertension

Additional Info

Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial

Further Reading

EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction–Associated Steatotic Liver Disease

Once-Weekly Semaglutide in Individuals With Obesity and Knee Osteoarthritis

Associations of Diabetes and Prediabetes With Mortality and Life Expectancy in Chinese Individuals

The Burden of Diabetes-Associated Multiple Long-Term Conditions on Years of Life Spent and Lost

Impact of GLP-1 Receptor Agonist–Based Treatments on Fat-Free Mass

Association Between Ultraprocessed Food Consumption and the Risk of Diabetes

Association of Glycaemic Risk Factors and Diabetes Duration With the Risk of Heart Failure in People With Type 2 Diabetes

Outcomes of Time-Restricted Eating in Adults With Metabolic Syndrome

Impact of Overweight and Obesity on Health Outcomes in the US From 1990 to 2021

The Effect of Semaglutide on Mortality and COVID-19–Related Deaths

Impact of GLP-1 RAs on Cardiorenal Outcomes and Mortality in People With Type 2 Diabetes and Acute Kidney Disease

Recently Updated